Use of Transcranial Magnetic Stimulation in the Post-Operative Cognitive Dysfunction in Elderly
Use of Transcranial Magnetic Stimulation in the Prevention of Post-Operative Cognitive Dysfunction in Elderly with Mild Neurocognitive Disorder
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Deise Ferreira, MSc
- Phone Number: +55 11 98032-0345
- Email: deise.fsilva@hc.fm.usp.br
Study Contact Backup
- Name: Clarice Tanaka, PhD
- Phone Number: +55 11 2661-6175
- Email: cltanaka@usp.br
Study Locations
-
-
-
Sao Paulo, Brazil, 01246903
- Recruiting
- University of Sao Paulo
-
Contact:
- Deise Ferreira, MSc
- Phone Number: +55 11 98032-0345
- Email: deise.fsilva@hc.fm.usp.br
-
Contact:
- Clarice Tanaka, PhD
- Phone Number: +55 11 2661-6175
- Email: cltanaka@usp.br
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients over 60 years old
- Patients scheduled for elective surgeries of moderate or large scale and candidates for general or spinal anesthesia;
- Patients who demonstrate possible or probable cognitive impairment based on pre-operative screening using the 10-CS (10-point cognitive screening) tool; - For Non-surgical Control Intervention Group, only the first and third criteria will be applied.
Exclusion Criteria:
- Contraindications for the use of Transcranial Magnetic Stimulation (metal implants in the head, history of seizures or epilepsy, brain trauma or surgery, intracranial hypertension, and complications from exposure to magnetic fields);
- Medical diagnosis of Major Neurocognitive Disorder (any form of dementia, regardless of the stage);
- Indication for skull surgery;
- Conditions that interfere with cognitive testing (presence of severe hearing and vision loss, inability to understand Portuguese);
- Ongoing medication adjustments that affect cortical electrical activity (antidepressants, antipsychotics);
- Difficulty attending treatment during the stipulated evaluation and follow-up period, whether due to socioeconomic or clinical reasons;
- Anticipation of surgical scheduling;
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Pre-surgical intervention group (PREG)
Participants in the Pre-surgical intervention group (PREG) will undergo active rTMS 15 days before surgery.
The protocol will be intermittent theta-burst (iTBS), with 3 pulses applied at 50Hz and modulated at 5Hz for 2s, repeated every 10s for a total of 120s, totaling 300 pulses, with intensity at 80% of the MRL.
The stimulated targets will be the left and right posterior parietal cortex (P3 and P4) and the left and right dorsolateral prefrontal cortex (F3 and F4), totaling 1200 pulses per day
|
Transcranial Magnetic Stimulation (TMS): A non-invasive brain stimulation (NIBS) technique that involves modulating brain excitability and activity, which can increase or decrease depending on the parameters used.
Theta Burst Stimulation (TBS) mimics the brain's natural firing patterns more closely and may have greater effects on cognitive performance.
Other Names:
|
|
Sham Comparator: Pre-surgical Control Group (PRECG)
Participants in the Pre-surgical Control Group (PRECG) will undergo simulated rTMS with a 90º coil tilt with the lower part facing the scalp 15 days before surgery.
The protocol will be intermittent theta-burst (iTBS), with 3 pulses applied at 50Hz and modulated at 5Hz for 2s, repeated every 10s for a total of 120s, totaling 300 pulses, with intensity at 80% of the MRL.
The stimulated targets will be the left and right posterior parietal cortex (P3 and P4) and left and right dorsolateral prefrontal cortex (F3 and F4), totaling 1200 pulses per day.
|
Theta Burst Stimulation simulated with 90º coil orientation with lower part external to the scalp.
Other Names:
|
|
Active Comparator: Non-surgical Control Intervention Group (COG)
Participants in the Non-Surgical Control Intervention Group (COG) will undergo active rTMS.
The protocol will be intermittent theta-burst (iTBS), with 3 pulses applied at 50Hz and modulated at 5Hz for 2s, repeated every 10s for a total of 120s, totaling 300 pulses, with intensity at 80% of the MRL.
The stimulated targets will be the left and right posterior parietal cortex (P3 and P4) and the left and right dorsolateral prefrontal cortex (F3 and F4), totaling 1200 pulses per day
|
Transcranial Magnetic Stimulation (TMS): A non-invasive brain stimulation (NIBS) technique that involves modulating brain excitability and activity, which can increase or decrease depending on the parameters used.
Theta Burst Stimulation (TBS) mimics the brain's natural firing patterns more closely and may have greater effects on cognitive performance.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Verbal Learning
Time Frame: 1st evaluation: Baseline. 2nd evaluation: 2 days after the application of the active or sham iTBS protocol. 3rd evaluation: 15 days after surgery (surgical groups) or 20 days after the second evaluation (non-surgical group). 4th evaluation: 3 months afte
|
Hopkins Verbal Learning Test (HVLT) - This test consists of a list of 12 words.
After the examiner reads the list, the patient is asked to repeat as many words as possible in any order.
This procedure is repeated two more times, and after 25 minutes, a delayed recall is requested.
The score is based on the number of words recalled in the delayed recall.
|
1st evaluation: Baseline. 2nd evaluation: 2 days after the application of the active or sham iTBS protocol. 3rd evaluation: 15 days after surgery (surgical groups) or 20 days after the second evaluation (non-surgical group). 4th evaluation: 3 months afte
|
|
Changes in Attention and Executive Function:
Time Frame: 1st evaluation: Baseline. 2nd evaluation: 2 days after the application of the active or sham iTBS protocol. 3rd evaluation: 15 days after surgery (surgical groups) or 20 days after the second evaluation (non-surgical group). 4th evaluation: 3 months afte
|
Trail Making Test (A and B) - The test is divided into two parts: the first part (TMT A) involves simple visual search and motor speed, while the second part (TMT B) requires complex visual search due to the alternation of stimuli, thus assessing executive function performance.
In part A, the person must connect numbered circles in ascending order.
In part B, they must draw lines alternating between numbers in ascending order and letters in alphabetical order.
The test evaluates not only selective and alternating attention but also complex visual tracking and motor dexterity (Part A) as well as executive processes (Part B).
The time spent and the number of errors made in each part are assessed.
|
1st evaluation: Baseline. 2nd evaluation: 2 days after the application of the active or sham iTBS protocol. 3rd evaluation: 15 days after surgery (surgical groups) or 20 days after the second evaluation (non-surgical group). 4th evaluation: 3 months afte
|
|
Changes in Attention and Processing Speed
Time Frame: 1st evaluation: Baseline. 2nd evaluation: 2 days after the application of the active or sham iTBS protocol. 3rd evaluation: 15 days after surgery (surgical groups) or 20 days after the second evaluation (non-surgical group). 4th evaluation: 3 months afte
|
Stroop Test - The Stroop test assesses selective attention, the ability to maintain focus on a task, and the inhibition of the tendency to provide impulsive responses, as well as the speed of information processing.
In this task, 99 trials are presented on a computer, featuring the words "green," "red," and "blue," displayed in their respective colors (or not).
It measures the response time to name the colors of words that are colored in their actual color (congruent trials) or to state the colors of words with different colors (incongruent trials).
It also evaluates the number of correct responses in the trials.
Data will be synchronized using MATLAB software.
|
1st evaluation: Baseline. 2nd evaluation: 2 days after the application of the active or sham iTBS protocol. 3rd evaluation: 15 days after surgery (surgical groups) or 20 days after the second evaluation (non-surgical group). 4th evaluation: 3 months afte
|
|
Changes in Motor Skills
Time Frame: 1st evaluation: Baseline. 2nd evaluation: 2 days after the application of the active or sham iTBS protocol. 3rd evaluation: 15 days after surgery (surgical groups) or 20 days after the second evaluation (non-surgical group). 4th evaluation: 3 months afte
|
The Grooved Pegboard Test - This is a manual dexterity test consisting of a board with 25 holes of the same shape (similar to a keyhole) and size, but arranged in a random orientation, along with small pegs that must be placed into the holes following a predetermined order, using only one hand.
The raw data corresponds to the time taken to complete the task, measured in seconds.
The dominant hand is tested first, followed by the non-dominant hand.
|
1st evaluation: Baseline. 2nd evaluation: 2 days after the application of the active or sham iTBS protocol. 3rd evaluation: 15 days after surgery (surgical groups) or 20 days after the second evaluation (non-surgical group). 4th evaluation: 3 months afte
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Evered L, Scott DA, Silbert B, Maruff P. Postoperative cognitive dysfunction is independent of type of surgery and anesthetic. Anesth Analg. 2011 May;112(5):1179-85. doi: 10.1213/ANE.0b013e318215217e. Epub 2011 Apr 7.
- Begemann MJ, Brand BA, Curcic-Blake B, Aleman A, Sommer IE. Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis. Psychol Med. 2020 Nov;50(15):2465-2486. doi: 10.1017/S0033291720003670. Epub 2020 Oct 19.
- Skvarc DR, Berk M, Byrne LK, Dean OM, Dodd S, Lewis M, Marriott A, Moore EM, Morris G, Page RS, Gray L. Post-Operative Cognitive Dysfunction: An exploration of the inflammatory hypothesis and novel therapies. Neurosci Biobehav Rev. 2018 Jan;84:116-133. doi: 10.1016/j.neubiorev.2017.11.011. Epub 2017 Nov 26.
- Chou YH, Ton That V, Sundman M. A systematic review and meta-analysis of rTMS effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2020 Feb;86:1-10. doi: 10.1016/j.neurobiolaging.2019.08.020. Epub 2019 Aug 27.
- Hoy KE, Bailey N, Michael M, Fitzgibbon B, Rogasch NC, Saeki T, Fitzgerald PB. Enhancement of Working Memory and Task-Related Oscillatory Activity Following Intermittent Theta Burst Stimulation in Healthy Controls. Cereb Cortex. 2016 Dec;26(12):4563-4573. doi: 10.1093/cercor/bhv193. Epub 2015 Sep 23.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 58398022.1.0000.0068
- 6.796.500 (Registry Identifier: PARECER)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.